Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tenderpoint and Ultrasound Guided Nerveblocks for Persistent Pain After Breast Cancer Surgery

NCT02336529 is registered in ClinicalTrials.gov with Kenneth Geving Andersen as lead sponsor.

NCT NCT02336529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02336529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tenderpoint and Ultrasound Guided Nerveblocks for Persistent Pain After Breast Cancer Surgery
Lead sponsor
Kenneth Geving Andersen
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2016
Completion date
July 31, 2017
Enrollment
48 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, neuropathic pain, pain